38.5K
Downloads
256
Episodes
A Cure In Sight (ACIS) is a nonprofit organization committed to improving the lives of those affected by ocular melanoma. Through education, patient support programs, advocacy, and research funding, ACIS works to raise awareness and accelerate progress toward better treatments and outcomes.
The Eye Believe Podcast, hosted by A Cure In Sight, brings together patients, caregivers, researchers, and medical professionals to share stories, discuss advances in ocular melanoma research, and highlight the strength of the community. The podcast’s mission is to inform, inspire, and give a voice to those impacted by ocular melanoma.
A Cure In Sight (ACIS) is a nonprofit organization committed to improving the lives of those affected by ocular melanoma. Through education, patient support programs, advocacy, and research funding, ACIS works to raise awareness and accelerate progress toward better treatments and outcomes.
The Eye Believe Podcast, hosted by A Cure In Sight, brings together patients, caregivers, researchers, and medical professionals to share stories, discuss advances in ocular melanoma research, and highlight the strength of the community. The podcast’s mission is to inform, inspire, and give a voice to those impacted by ocular melanoma.
Episodes
Thursday Feb 15, 2024
Making Meaning of the Cancer Journey: 2024 Eye on Mental Health Session 1
Thursday Feb 15, 2024
Thursday Feb 15, 2024
Ocular Melanoma is a beast of a diagnosis. Fellow cancer survivor and patient Eve Bogdanove shares strategies for coping with your diagnosis and making meaning throughout the journey.
Eve N. Bogdanove has been a clinical social worker for 28 years. She is a psychodynamically trained with additional training in IFS, SE, EMDR, DBT and is a AASECT Certified Sex & Gender Therapist. She has expertise in CPTSD and working with perpetrators who harm their intimate partners.
Our mini seminar this year was brought to you by Castle Biosciences, as well as Aura Biosciences, Immunocore, IDEAYA Biosciences, Delcath Systems, and Trisalus Life Sciences.

No comments yet. Be the first to say something!